TVM just shy of €250m target
Technology and life science-focused venture capital firm TVM has raised €240.3 million from European, US and Asian investors to invest in drug discovery and development.
16 January 2013•2 mins read
Technology and life science-focused venture capital firm TVM has raised €240.3 million from European, US and Asian investors to invest in drug discovery and development.
